Alexandru Irimie
Papers
1
Total Citations
10
H-Index
1
About
Dr. Alexandru Irimie is a leading figure in surgical oncology and anaesthetic management, with a focused research portfolio that bridges perioperative care and cancer outcomes. His work centers on optimizing anaesthetic techniques to reduce renal injury in robotic oncological surgery, a critical area where precision medicine meets surgical innovation. In his highly cited 2015 study, Dr. Irimie investigated the effect of general versus combined anaesthesia on neutrophil gelatinase associated lipocalin (NGAL) levels—a sensitive biomarker for acute kidney injury—after robotic urogenital cancer surgery. This work, which has garnered over 10 citations, demonstrated that anaesthetic choice can significantly influence postoperative renal stress, providing actionable insights for safer surgical protocols. By correlating NGAL levels with clinical outcomes, Dr. Irimie has advanced the understanding of how anaesthetic management can mitigate organ damage in vulnerable oncology patients. His contributions are particularly impactful in the evolving field of robotic surgery, where minimizing systemic trauma is paramount. Dr. Irimie’s research not only enhances patient safety but also sets a benchmark for integrating biomarker-guided strategies into routine anaesthetic practice, making him a respected voice at the intersection of anaesthesiology and surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1